Trial · NCT02531633
Participant flow70
How many started, completed or left each group, period by period.
1 to 20 of 70
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Part A (52 Weeks) | STARTED | Part A:SIR 100 mg SC q2w+6 Month Prednisone | 42 | |
| Part A (52 Weeks) | STARTED | Part A:SIR 100 mg SC q2w+3 Month Prednisone | 39 | |
| Part A (52 Weeks) | STARTED | Part A:SIR 50 mg SC q4w+6 Month Prednisone | 26 | |
| Part A (52 Weeks) | STARTED | Part A:Placebo SC q2w + 6 Month Prednisone | 27 | |
| Part A (52 Weeks) | STARTED | Part A:Placebo SC q2w+12 Month Prednisone | 27 | |
| Part A (52 Weeks) | STARTED | Part B:SIR 100 mg SC q2w+6 Month Prednisone | 0 | |
| Part A (52 Weeks) | STARTED | Part B:SIR 100 mg SC q2w+3 Month Prednisone | 0 | |
| Part A (52 Weeks) | STARTED | Part B:SIR 50 mg SC q4w+6 Month Prednisone | 0 | |
| Part A (52 Weeks) | STARTED | Part B:Placebo SC q2w + 6 Month Prednisone | 0 | |
| Part A (52 Weeks) | STARTED | Part B:Placebo SC q2w + 12 Month Prednisone | 0 | |
| Part A (52 Weeks) | Completed Part A and Didn't Enter Part B | Part A:SIR 100 mg SC q2w+6 Month Prednisone | 1 | |
| Part A (52 Weeks) | Completed Part A and Didn't Enter Part B | Part A:SIR 100 mg SC q2w+3 Month Prednisone | 0 | |
| Part A (52 Weeks) | Completed Part A and Didn't Enter Part B | Part A:SIR 50 mg SC q4w+6 Month Prednisone | 1 | |
| Part A (52 Weeks) | Completed Part A and Didn't Enter Part B | Part A:Placebo SC q2w + 6 Month Prednisone | 0 | |
| Part A (52 Weeks) | Completed Part A and Didn't Enter Part B | Part A:Placebo SC q2w+12 Month Prednisone | 0 | |
| Part A (52 Weeks) | Completed Part A and Didn't Enter Part B | Part B:SIR 100 mg SC q2w+6 Month Prednisone | 0 | |
| Part A (52 Weeks) | Completed Part A and Didn't Enter Part B | Part B:SIR 100 mg SC q2w+3 Month Prednisone | 0 | |
| Part A (52 Weeks) | Completed Part A and Didn't Enter Part B | Part B:SIR 50 mg SC q4w+6 Month Prednisone | 0 | |
| Part A (52 Weeks) | Completed Part A and Didn't Enter Part B | Part B:Placebo SC q2w + 6 Month Prednisone | 0 | |
| Part A (52 Weeks) | Completed Part A and Didn't Enter Part B | Part B:Placebo SC q2w + 12 Month Prednisone | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02531633/flow